In-silico guided discovery of novel CCR9 antagonists
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Computer-Aided Molecular Design"
DOI: 10.1007/s10822-018-0113-2
Abstract: Antagonism of CCR9 is a promising mechanism for treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s disease. There is limited experimental data on CCR9 and its ligands, complicating efforts to identify new small… read more here.
Keywords: novel ccr9; ccr9 antagonists; guided discovery; silico guided ... See more keywords